CLGN
Collplant Biotechnologies Ltd
NASDAQ: CLGN · HEALTHCARE · BIOTECHNOLOGY
$0.37
-4.51% today
Updated 2026-04-29
Market cap
$6.00M
P/E ratio
—
P/S ratio
2.53x
EPS (TTM)
$-0.94
Dividend yield
—
52W range
$0 – $5
Volume
0.1M
Collplant Biotechnologies Ltd (CLGN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0.00 | $0.00 | $75911.00 | $479917.00 | $4.79M | $2.32M | $6.14M | $15.64M | $299000.00 | $10.96M | $515000.00 | $2.37M |
| Revenue growth (YoY) | — | — | — | — | — | +532.2% | +897.8% | -51.6% | +164.8% | +154.9% | -98.1% | +3565.2% | -95.3% | +360.4% |
| Cost of revenue | $316612.00 | $263470.00 | $224198.00 | $202819.00 | $225072.00 | $306090.00 | $1.90M | $2.27M | $3.46M | $2.00M | $1.48M | $3.09M | $2.66M | $1.75M |
| Gross profit | $-316612.00 | $-263470.00 | $-224198.00 | $-202819.00 | $-149006.00 | $157632.00 | $3.11M | $52000.00 | $2.68M | $13.64M | $-1.18M | $7.87M | $-2.15M | $624000.00 |
| Gross margin | — | — | — | — | -196.3% | 32.8% | 65.0% | 2.2% | 43.7% | 87.2% | -393.6% | 71.8% | -417.1% | 26.3% |
| R&D | $3.27M | $3.57M | $2.50M | $3.04M | $4.36M | $4.05M | $5.16M | $4.41M | $3.66M | $7.63M | $10.26M | $10.48M | $10.52M | $8.19M |
| SG&A | $1.28M | $1.01M | $945060.00 | $1.77M | $2.86M | $2.38M | $3.29M | $3.62M | $4.62M | $5.94M | $6.74M | $6.55M | $5.63M | $4.83M |
| Operating income | $-4.64M | $-4.65M | $-3.50M | $-4.82M | $-7.16M | $-5.97M | $-4.07M | $-7.63M | $-5.60M | $65000.00 | $-17.10M | $-7.51M | $-17.25M | $-11.48M |
| Operating margin | — | — | — | — | -9433.2% | -1244.2% | -84.9% | -329.2% | -91.2% | 0.4% | -5718.1% | -68.5% | -3349.7% | -484.3% |
| EBITDA | $-4.14M | $-4.30M | $-3.41M | $-4.60M | $-7.03M | $-5.41M | $-5.88M | $-10.55M | $-5.08M | $1.05M | $-15.81M | $-5.91M | $-15.55M | $-10.57M |
| EBITDA margin | — | — | — | — | -9254.5% | -1126.8% | -122.8% | -455.2% | -82.8% | 6.7% | -5289.3% | -53.9% | -3020.2% | -445.8% |
| EBIT | $-4.47M | $-4.57M | $-3.62M | $-4.80M | $-7.25M | $-5.70M | $-6.22M | $-11.09M | $-5.74M | $274000.00 | $-16.89M | $-7.01M | $-16.59M | $-11.48M |
| Interest expense | $11777.00 | $7753.00 | $6988.00 | $13064.00 | $15890.00 | $105644.00 | $26000.00 | $73000.00 | $34000.00 | $37000.00 | $34000.00 | $10000.00 | $17000.00 | $15000.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-4.46M | $-4.56M | $-3.64M | $-4.80M | $-7.27M | $-5.80M | $-6.25M | $-11.16M | $-5.77M | $237000.00 | $-16.93M | $-7.02M | $-16.61M | $-11.49M |
| Net income growth (YoY) | — | -2.4% | +20.2% | -31.9% | -51.4% | +20.1% | -7.7% | -78.7% | +48.3% | +104.1% | -7241.4% | +58.5% | -136.6% | +30.8% |
| Profit margin | — | — | — | — | -9571.9% | -1209.6% | -130.5% | -481.6% | -94.1% | 1.5% | -5660.5% | -64.0% | -3225.0% | -484.6% |